Literature DB >> 19768633

Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease.

Julia L Newton1, Jessie Pairman, Katharine Wilton, David E J Jones, Christopher Day.   

Abstract

BACKGROUND: Fatigue is a significant symptom in nonalcoholic fatty liver disease (NAFLD) that impacts upon quality of life and is unrelated to liver disease severity. We examined the relationship between parameters of blood pressure regulation with perception of fatigue in NAFLD.
METHODS: Thirty-four non-diabetic subjects with histologically proven, non-cirrhotic NAFLD (26 [77%] males and 8 [23%] females) (mean +/- SD age 54 +/- 11) and 34 age, sex and BMI matched non-diabetic controls underwent subjective and objective evaluation of cardiovascular autonomic function (24 h blood pressure and head up tilt testing). All subjects completed the fatigue impact scale.
RESULTS: The NAFLD group had significantly higher autonomic symptom burden assessed using the orthostatic grading scale (OGS) compared to controls (4 +/- 4 vs. 1 +/- 2; p = 0.0003). Increasing orthostatic symptoms correlated with increasing fatigue (p = 0.006; r(2) = 0.3). Fatigue in NAFLD correlated inversely with 24 h measurement of systolic, diastolic and mean blood pressures (all p < 0.03; r(2) = 0.2). This relationship was predominantly related to lower blood pressure at night (p < 0.003; r(2) = 0.3). On head up tilt testing 57% of the NAFLD group had neurally-mediated hypotension (vasovagal syncope and/or orthostatic hypotension) (p = 0.006 compared to controls). The degree of blood pressure drop in response to standing correlated with fatigue severity (p = 0.008; r(2) = 0.3) and the autonomic symptom burden (OGS) (p = 0.03; r(2) = 0.2).
CONCLUSION: Autonomic symptoms are prevalent in NAFLD and associate with objective measures of autonomic dysfunction. Fatigue in NAFLD is associated with lower blood pressure and autonomic dysfunction. Studies are needed to determine whether this is a potential therapeutic target for fatigue in NAFLD.

Entities:  

Mesh:

Year:  2009        PMID: 19768633     DOI: 10.1007/s10286-009-0031-4

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  51 in total

1.  Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome.

Authors:  Robert W Haley; Wanpen Vongpatanasin; Gil I Wolfe; Wilson W Bryan; Roseanne Armitage; Robert F Hoffmann; Frederick Petty; Timothy S Callahan; Elizabeth Charuvastra; William E Shell; W Wesley Marshall; Ronald G Victor
Journal:  Am J Med       Date:  2004-10-01       Impact factor: 4.965

2.  Insulin resistance may be involved in relationship between cardiac autonomic dysfunction and polycystic ovary syndrome.

Authors:  Antonio Perciaccante; Alessandra Fiorentini
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-10       Impact factor: 1.468

3.  The Newcastle protocols 2008: an update on head-up tilt table testing and the management of vasovagal syncope and related disorders.

Authors:  S W Parry; P Reeve; J Lawson; F E Shaw; J Davison; M Norton; R Frearson; S Kerr; J L Newton
Journal:  Heart       Date:  2008-08-13       Impact factor: 5.994

4.  Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

Authors:  M I Prince; O F James; N P Holland; D E Jones
Journal:  J Hepatol       Date:  2000-03       Impact factor: 25.083

5.  Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance.

Authors:  Hidetaka Tanaka; Reiko Matsushima; Hiroshi Tamai; Yoshinaga Kajimoto
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

Review 6.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy.

Authors: 
Journal:  J Neurol Sci       Date:  1996-12       Impact factor: 3.181

7.  Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment.

Authors:  M G Swain; M Maric
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

8.  Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis.

Authors:  Julia L Newton; John Allen; Simon Kerr; David E J Jones
Journal:  Liver Int       Date:  2006-03       Impact factor: 5.828

9.  Blood mobilization from the liver of the anaesthetized dog.

Authors:  B J Noble; M J Drinkhill; D S Myers; R Hainsworth
Journal:  Exp Physiol       Date:  1998-07       Impact factor: 2.969

10.  Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.

Authors:  I J Hickman; J R Jonsson; J B Prins; S Ash; D M Purdie; A D Clouston; E E Powell
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

View more
  24 in total

1.  Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure.

Authors:  W-F Ng; A J Stangroom; A Davidson; K Wilton; S Mitchell; J L Newton
Journal:  QJM       Date:  2012-09-13

Review 2.  Biobehavioral Mechanisms Associated With Nonhealing Wounds and Psychoneurologic Symptoms (Pain, Cognitive Dysfunction, Fatigue, Depression, and Anxiety) in Older Individuals With Chronic Venous Leg Ulcers.

Authors:  Joyce K Stechmiller; Debra Lyon; Gregory Schultz; Daniel J Gibson; Michael T Weaver; Diana Wilkie; Anastasiya V Ferrell; Joanne Whitney; Junglyun Kim; Susan B Millan
Journal:  Biol Res Nurs       Date:  2019-05-29       Impact factor: 2.522

3.  Non-alcoholic fatty liver disease is not associated with a lower health perception.

Authors:  Liat Mlynarsky; Dalit Schlesinger; Roni Lotan; Muriel Webb; Zamir Halpern; Erwin Santo; Oren Shibolet; Shira Zelber-Sagi
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

Review 4.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 5.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 6.  Shared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research.

Authors:  Victoria Menzies; Nancy Jallo; Patricia Kinser; Jo Lynne W Robins; Kyungeh An; Carolyn Driscoll; Angela Starkweather; Jasmohan S Bajaj; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2014-07-18       Impact factor: 2.522

7.  Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up.

Authors:  Chris Elliott; James Frith; Christopher P Day; David E J Jones; Julia L Newton
Journal:  Dig Dis Sci       Date:  2013-04-23       Impact factor: 3.199

Review 8.  Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.

Authors:  Zobair M Younossi; Linda Henry
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

9.  Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Authors:  Lisa B VanWagner; Mary E Rinella
Journal:  Curr Hepatol Rep       Date:  2016-03-28

Review 10.  Hepatic Nervous System in Development, Regeneration, and Disease.

Authors:  Bess M Miller; Isaac M Oderberg; Wolfram Goessling
Journal:  Hepatology       Date:  2021-08-15       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.